Dilated cardiomyopathy and limb-girdle muscular dystrophy-dystroglycanopathy due to novel pathogenic variants in the DPM3 gene.


Journal

Neuromuscular disorders : NMD
ISSN: 1873-2364
Titre abrégé: Neuromuscul Disord
Pays: England
ID NLM: 9111470

Informations de publication

Date de publication:
07 2019
Historique:
received: 06 04 2018
revised: 14 04 2019
accepted: 07 05 2019
pubmed: 4 7 2019
medline: 28 7 2020
entrez: 4 7 2019
Statut: ppublish

Résumé

Deficiency of Dolichol-P-mannose synthase subunit 3 (DPM3) affects the N-glycosylation and O-mannosylation pathways that are respectively involved in congenital disorders of glycosylation (CDG) and alpha-dystroglycanopathies. Herein, we describe novel pathogenic variants in the DPM3 gene in two unrelated male patients. They developed dilated cardiomyopathy in their late teens, limb-girdle muscular dystrophy - one patient in childhood and the other in adulthood. In both patients, next generation sequencing found in the DPM3 gene a heterozygous deletion and a heterozygous pathogenic missense mutation in exon 2 (c.41T>C, p.Leu14Pro). Electrophoresis of serum transferrin found an abnormal N-glycosylation profile suggestive of CDG type 1 (decreased tetrasialotransferrin, increased disialo- and asialotransferrin). Only two cases of DPM3 gene mutations with limb-girdle muscular dystrophy-dystroglycanopathy have been reported previously. The present study highlights several aspects related to DPM3 gene mutations such as mild to moderately severe limb-girdle muscular dystrophy, dilated cardiomyopathy, and abnormal N-glycosylation profile suggestive of CDG type 1.

Identifiants

pubmed: 31266720
pii: S0960-8966(18)30229-3
doi: 10.1016/j.nmd.2019.05.004
pii:
doi:

Substances chimiques

Membrane Proteins 0
Transferrin 0
Mannosyltransferases EC 2.4.1.-
DPM3 protein, human EC 2.4.1.109

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

497-502

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

J Svahn (J)

Electroneuromyography and Neuromuscular Department, Hospices Civils de Lyon, Lyon, France. Electronic address: juliette.svahn@chu-lyon.fr.

P Laforêt (P)

Centre de référence des maladies neuromusculaires Nord/Est/Ile de France, Service de Neurologie, Hôpital Raymond-Poincaré, Garches, AP-HP/ INSERM U1179, END-ICAP, Université Versailles Saint-Quentin-en-Yvelines, Montigny-le-Bretonneux, France.

C Vial (C)

Electroneuromyography and Neuromuscular Department, Hospices Civils de Lyon, Lyon, France.

N Streichenberger (N)

Department of Neuropathology, Hospices Civils de Lyon, Lyon, France.

N Romero (N)

Myology Institute, Neuromuscular Morphology Unit, Groupe Hospitalier Universitaire La Pitié-Salpêtrière, Sorbonne Universités UPMC Univ Paris 06, Paris, France.

C Bouchet-Séraphin (C)

APHP, Bichat Hospital, Biochemistry, Paris, France.

A Bruneel (A)

APHP, Bichat Hospital, Biochemistry, Paris, France.

T Dupré (T)

APHP, Bichat Hospital, Biochemistry, Paris, France.

N Seta (N)

APHP, Bichat Hospital, Biochemistry, Paris, France.

R Menassa (R)

Department of Molecular Endocrinology and Rare Diseases, Hospices Civils de Lyon, Lyon, France.

L Michel-Calemard (L)

Department of Molecular Endocrinology and Rare Diseases, Hospices Civils de Lyon, Lyon, France.

T Stojkovic (T)

Myology Institute, Neuromuscular Pathology Reference Center, Groupe Hospitalier Universitaire La Pitié-Salpêtrière, Sorbonne Universités UPMC Univ Paris 06, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH